Here we describe chemical innovations that enable the preparation of fully synthetic tetracyclines containing an all-carbon quaternary, stereogenic center at position C5a, a structurally novel class of compounds in this important family of therapeutic agents. In the key transformation and an important extension of the powerful MichaeleClaisen cyclization (AB plus D) approach to the construction of fully synthetic tetracyclines, we show that the six-membered C ring comprising a C5a quaternary carbon center can be assembled by highly stereocontrolled coupling reactions of b-substituted AB enones and otoluate ester anion D-ring precursors. Novel and versatile b-functionalization reaction sequences employing tris(methylthio)methyllithium and 2-lithio-1,3-dithiane have been developed to transform the AB enone 1 (the key precursor to fully synthetic tetracyclines) into a diverse range of b-substituted AB enone products, including a highly efficient, single-operation method for the synthesis of a b-methyl ester-substituted AB enone. A C5aeC11a-bridged cyclopropane tetracycline precursor was found to undergo efficient and regioselective ring-opening reactions with a range of nucleophiles in the presence of magnesium bromide, thus providing another avenue for the preparation of fully synthetic tetracyclines containing an all-carbon quaternary center at position C5a. Two compounds prepared from the bridged cyclopropane intermediate served as (further) diversifiable branch-points, allowing maximally expedient synthesis of C5a-substituted tetracyclines by final-step diversification.
Introduction
To date more than 3000 fully synthetic molecules of the tetracycline class, broadly defined, have been prepared by a general and convergent process that involves a MichaeleClaisen coupling of the AB enone 1 with structurally diverse D-ring precursors followed by deprotection, a route of typically 3e4 steps (Fig. 1) . 1, 2 Most of the candidate antibiotics prepared in this way would have been difficult if not impossible to obtain by chemical transformations of natural tetracyclines ('semisynthetic' processes). A key enablement that permitted the development of this streamlined route was the introduction by Stork and Hagedorn of the 3-benzyloxyisoxazole function as a masked form of the vinylogous carbamic acid of the A ring of tetracyclines, a protective group that is readily cleaved by hydrogenolysis. 3 It is therefore appropriate that the present report, in which we build upon our earlier work through methodological advances that permit for the first time modification of position C5a of the tetracycline scaffold, appear in this special publication dedicated to Professor Gilbert Stork, a pioneering investigator in synthetic organic chemistry of extraordinary accomplishment.
Previous work has demonstrated that our fully synthetic approach to tetracyclines allows modifications at positions C6eC10 that are not feasible by semisynthesis. 1, 2 One area of focus in our current research is the development of chemical pathways that enable modifications at other positions, such as C5a, that have not previously been viable. Position C5a is one of two points of fusion of the B and C rings of tetracyclines and, as such, substitution of this position gives rise to a quaternary carbon center. Inspection of X-ray crystallographic data of tetracycline bound to the 30S subunit of the ribosome of Thermus Thermophilus suggests that substitution of position C5a would not obviously impede ribosome binding and thus could present an interesting and unexplored avenue for the discovery of potential new antibiotics to address problems such as bacterial resistance. 4, 5 To apply our general route for tetracycline synthesis to C5a-substituted analogs it was first necessary to develop methodology to prepare AB enones containing different b-substituents, and then to determine if these modified AB enones would successfully undergo MichaeleClaisen cyclization reactions with D-ring precursors, transformations that would give rise to a quaternary, stereogenic center at position C5a. The most rapid and straightforward approach to the synthesis of b-substituted AB enones appeared to be the direct functionalization of the AB enone 1. While introduction of simple alkyl groups such as b-methyl proved to be relatively straightforward (though low-yielding), introduction of more highly oxidized b-substituents was less so, and provided us with the opportunity to pursue a number of chemical innovations, which we detail herein. The subsequent stereocontrolled construction of the C ring, comprising an all-carbon quaternary center at position C5a, was viewed to be a challenging transformation, and its successful implementation we view to be a significant advance. During the course of our investigations we also serendipitously discovered a C5aeC11a bridged cyclopropanecontaining tetracycline intermediate that has proven to be an extraordinarily versatile precursor to a diverse array of C5a-substituted tetracyclines, providing another avenue for the synthesis of this novel class of substituted tetracycline antibiotics.
Results and discussion

New methods for b-functionalization of enones
As a first step toward the stereocontrolled construction of allcarbon quaternary, C5a-substituted tetracyclines we first sought to develop methods to transform the AB enone 1 into b-substituted AB enones as novel cyclization substrates (Schemes 1e3 below). A conventional reaction sequence served for the synthesis of the simple b-methyl-substituted AB enone 3 (Scheme 1). Specifically, conjugate addition of lithium dimethylcuprate to the AB enone 1 in the presence of trimethylsilylchloride 6 afforded the corresponding b-methyl-substituted trimethylsilyl enol ether 2 in 85% yield (1D- NOESY experiments support the 5a-S-stereochemistry depicted, in accord with all precedent in this system); 1 oxidation of this intermediate with palladium acetate in dimethyl sulfoxide (DMSO) at 80 C then afforded the b-methyl-substituted AB enone 3 in modest yield (44% yield on 160-mg scale, and 34% yield on 2.8-g scale). 7, 8 Attempted oxidation of the intermediate trimethylsilyl enol ether 2 with the alternative oxidant o-iodoxybenzoic acid (IBX) was not successful. 9 To transform the AB enone 1 into b-substituted AB enones with more highly oxidized b-substituents we were led to explore novel chemistry, as precedented methods were deemed to be too indirect or were impracticable in the present application.
10e12 First, we developed a versatile sequence for b-functionalization of the AB enone 1 initiated by conjugate addition of the Seebach reagent tris(methylthio)methyllithium 13 (THF, À78/À45 C) followed by trapping of the resulting enolate at À45 C with chlorotrimethylsilane. 14 The corresponding b-tris(methylthio)methyl trimethylsilyl enol ether (4) was isolated as a single stereoisomer (stereochemistry not determined) in 89% yield after purification by flash-column chromatography. We found that oxidation of the trimethylsilyl enol ether function and transformation of the tris(methylthio)methyl group occurred simultaneously upon treatment of a solution of 4 in the solvent mixture 500:1 methanol/water with an excess of N-bromosuccinimide (NBS, 5 equiv) at 23 C, affording the AB enone containing a b-methyl ester substituent (5) in 85%
yield. The detailed mechanism of the transformation of the intermediate 4 into the b-substituted AB enone 5 is not known, but presumably involves some variation of a sequence involving abromination of the trimethylsilyl enol ether, bromonium-induced conversion of the tris(methylthio)methyl substituent into the corresponding methyl ester (with incorporation of one molar equivalent each of methanol and water), and elimination of hydrogen bromide. By modification of the reaction solvent we found that different esters could be synthesized, including active esters. For example, addition of NBS (5 equiv) to a solution of the trimethylsilyl enol ether 4 in 2,2,2-trifluoroethanol and water (500:1 mixture) at 23 C afforded the corresponding b-trifluoroethyl ester-substituted
In a further optimization, we found that transformation of the bunsubstituted AB enone 1 to the b-methyl ester-substituted AB enone 5 could be achieved directly, and most efficiently (90% yield), in a single operation (Scheme 2).
A related strategy was effective for the synthesis of the AB enone b-substituted AB enone substrates, we next investigated the feasibility of constructing the C ring of tetracyclines with an allcarbon quaternary C5a stereocenter by a MichaeleClaisen cyclization reaction (Scheme 4). The D-ring precursors 12 (with OBoc protection at 'C10') and 13 (with OBn protection at 'C10') were chosen for initial cyclization experiments. These precursors comprise the D-ring functionality of minocycline (Scheme 4) and are known from prior research to be highly effective substrates in MichaeleClaisen cyclization reactions.
1b Addition of the b-methyl- (TMEDA, 6 equiv) at À78 C, followed by warming to À10 C, provided the MichaeleClaisen cyclization product 14 in 80% yield as a single stereoisomer after purification by flash-column chromatography. A minor by-product (<5%), thought to be the product of 1,2-additionecyclization (by lactonization), was isolated separately. The stereochemical assignment of the MichaeleClaisen cyclization product (14) , with C5a-R configuration, is supported by NOE studies; this stereochemistry is homologous with that of MichaeleClaisen cyclization products derived from the nonsubstituted AB enone 1. we are unaware of any examples beyond those described here of the stereocontrolled construction of a six-membered ring containing a quaternary center by a MichaeleClaisen cyclization reaction.
MichaeleClaisen reaction of the b-methoxymethoxymethyl AB enone 10 and the minocycline D-ring precursor 13 (chosen so as to allow later deprotection of the methoxymethyl ether at C5a without concomitant cleavage of the C10 phenoxy protective group) was also efficient, affording the cyclization product 15, with a protected C5a-hydroxymethyl-substituted quaternary center, in 72% yield (Scheme 4). Reaction of the b-methyl ester AB enone 5
with the anion formed from the minocycline D-ring precursor 12 afforded a complex mixture of products containing the desired MichaeleClaisen cyclization product 16 as one component. Cycloadduct 16 was isolated in 23% yield after purification by sequential flash-column chromatography and reverse-phase highperformance liquid chromatography (rp-HPLC). Two-step deprotection of cyclization products 14 and 16 under typical conditions 1, 3 provided C5a-methylminocycline (17, 100% yield, Scheme 5) and C5a-carbomethoxyminocycline (18, 89% yield), respectively, after purification by rp-HPLC. Thus, hydrogenolytic deprotection of the 3-benzyloxyisoxazole function, as reported by Stork and Hagedorn, 3 reveals the vinylogous carbamic acid function of the A ring of tetracyclines in the final step of the synthetic sequence.
Discovery and diversification of a C5aeC11a bridged cyclopropane-containing tetracycline intermediate
In a search for a versatile branch point for the synthesis of various C5a-substituted tetracyclines we were led to a serendipitous but highly effective solution (Scheme 6). Removal of the methoxymethyl ether protective group within the MichaeleClaisen cyclization product 15 was achieved by treatment with perchloric acid (CAUTION!), 21 providing the substituted neopentyl alcohol 19 (73% yield). Addition of phosgene to a solution of 19 in dichloromethane/pyridine (10:1) at 0 C unexpectedly afforded the C5aeC11a-bridged cyclopropane tetracycline precursor 20 in 81% yield. After the fact, the formation of 20 is easily rationalized. In this context it is interesting to note that Barton et al. had previously reported that the (C11,C12) 1,3-diketone can participate in an internal nucleophilic addition, albeit in that case with addition to an electrophilic carbonyl group that had been introduced at position C4.
22
Cyclopropanes with geminal electron-withdrawing substituents are known to undergo nucleophilic ring-opening, 23 a transformation often enhanced in the presence of Lewis acids. 24 We were led to explore the use of magnesium salts as Lewis acid activators in this system in view of the well documented affinity of Mg 2þ for binding to the (C11,C12) 1,3-diketone function of tetracyclines, complexation which is critical for inhibition of the ribosome. 4 We observed that the bridged cyclopropane intermediate 20 underwent regioselective ring-opening at the bridging carbon atom in the presence of various nucleophiles and magnesium bromide as Lewis acid. The ring-opened products were readily deprotected in the typical two-step sequence to furnish the corresponding C5a-substituted tetracyclines (Table 1) . For example, reaction of the C5aeC11a-bridged cyclopropane tetracycline precursor 20 with pyrrolidine (10 equiv) in the presence of a stoichiometric amount of anhydrous magnesium bromide in THF at 23 C, followed by direct deprotection of the crude ring-opened product (21) , provided C5a-pyrrolidinomethylminocycline (22) in 74% yield over the three steps after purification by rp-HPLC. A number of different amines and alcohols were found to function effectively as nucleophiles in the magnesium bromide-promoted cyclopropane ring-opening reaction (Table 1) . Ring-opening reactions were typically performed with a large excess of nucleophile (!7 equiv) and stoichiometric or superstoichiometric quantities of anhydrous magnesium bromide in THF (in the cases of low molecular weight alcohols as nucleophiles, the alcohol was used as solvent) at a range of temperatures (23e75 C, see Experimental section for details). Partial (and inconsequential) loss of the benzyl ether phenolic protective group was observed to occur in the cyclopropane ring-opening reaction in some instances. The C5aeC11a-bridged cyclopropane intermediate 20 also served as a precursor to tetracyclines with aminomethyl (32) and piperazinylmethyl (34) substituents at position C5a (Scheme 7), highly versatile compounds which functioned as further branchpoints for the synthesis of C5a-substituted tetracyclines (Figs. 2  and 3 ). Thus, treatment of cyclopropane 20 with sodium azide in dimethylformamide at 23 C afforded the azido-substituted ringopened product 31 in 78% yield after purification by flash-column chromatography. 25 Addition of trimethylphosphine (2 equiv) to a solution of the azide 31 and 2-(tert-butoxycarbonyloxyimino)-2-phenylacetonitrile (BoceON, 2 equiv) in THF at À10 C followed by warming to 23 C afforded the corresponding tert-butyl carbamate (51% yield). 26 Two-step deprotection of the tert-butyl carbamate intermediate was best achieved by an inverted deprotection sequence (hydrogenolysis followed by treatment with hydrofluoric acid), 27 providing C5a-aminomethylminocycline 32 after purification by rp-HPLC (69% yield over two steps). In addition, magnesium bromide-promoted ring-opening of cyclopropane 20 with N-tertbutoxycarbamyl-piperazine followed by deprotection of the ringopened product 33 provided C5a-piperazinylmethylminocycline (34, 58% yield over three steps). Final-step diversification of 32 and 34 was readily achieved, affording a range of novel tetracyclines with C5a substituents incorporating amides, sulfonamides, and amines (Figs. 2 and 3 ). In this manner the C5aeC11a-bridged cyclopropane 20 served as a common precursor for the synthesis of more than 25 structural variants of minocycline with a diverse range of substituents at C5a.
Conclusion
Synthetic methodological advances have permitted efficient and stereocontrolled construction of diverse fully synthetic tetracyclines containing an all-carbon quaternary center at position C5a. These examples serve to further demonstrate the broad applicability of the MichaeleClaisen cyclization reaction as a powerful method for the assembly of stereochemically complex sixmembered rings. 28 New strategies presented herein for the introduction of ester, thioester, and aldehyde substituents at the forming cyclization reactions of b-substituted AB enones described herein, combined with the extraordinary number and diversity of D-ring precursors known to be effective nucleophiles in this key coupling reaction, implies that a multiplicative expansion of the pool of fully synthetic tetracyclines is achievable, in the sense that each modified AB enone could in theory be coupled with the hundreds of different D-ring precursors that have been found to be effective coupling partners with the AB enone 1. 4. Experimental
General experimental procedures
All reactions were performed in round-bottom flasks fitted with rubber septa under a positive pressure of argon, unless otherwise noted. Air-and moisture-sensitive liquids were transferred via syringe or stainless steel cannula. Organic solutions were concentrated by rotary evaporation (house vacuum, ca. 25e40 Torr) at ambient temperature, unless otherwise noted. Analytical thin-layer chromatography (TLC) was performed using glass plates pre-coated with silica gel (0.25 mm, 60 A pore-size, 230e400 mesh, Merck KGA) impregnated with a fluorescent indicator (254 nm). TLC plates were visualized by exposure to ultraviolet light, then were stained with aqueous potassium permanganate solution. Flash-column chromatography was performed as described by Still et al., 29 employing silica gel (60 A, 32e63 mm, standard grade, Dynamic Adsorbents, Inc.).
Materials. Commercial solvents and reagents were used as received with the following exceptions. Diisopropylamine, TMEDA, chlorotrimethylsilane, and hexamethylphosphoramide were distilled from calcium hydride under an atmosphere of argon or dinitrogen. Tetrahydrofuran was purified by the method of Pangborn et al. 30 The molarity of n-butyllithium solutions was determined by titration against a standard solution of diphenylacetic acid in tetrahydrofuran (average of three determinations). 95 mmol, 1.6 equiv) was flame-dried under high vacuum. After cooling to room temperature, the flask was blanketed with dry argon. Tetrahydrofuran (50 mL) was added and the resulting suspension was cooled to 0 C. A solution of methyllithium in ethyl ether (1.6 M, 12.2 mL, 19.6 mmol, 3.15 equiv) was added dropwise via syringe over 5 min. The resulting solution was stirred at 0 C for 20 min, then was cooled to À78 C. A solution of the AB enone 1 (3.0 g, 6.22 mmol, 1 equiv) and chlorotrimethylsilane (1.25 mL, 9.95 mmol, 1.6 equiv) in tetrahydrofuran (10 mL) was added to the cuprate solution dropwise via syringe at À78 C. After stirring at À78 C for 90 min, the cooling bath was removed and the product solution was diluted with ethyl acetate (100 mL) and hexanes (100 mL). A mixture of saturated aqueous ammonium chloride solution and saturated aqueous ammonium hydroxide solution (19:1, 100 mL) was then added carefully. The phases were separated and the organic phase was washed sequentially with saturated aqueous ammonium chloride solution (100 mL) and saturated aqueous sodium chloride solution (2Â100 mL). The organic phase was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The product was purified by flash-column chromatography (7% ethyl acetate/ hexanes), providing b-methyl-substituted trimethylsilyl enol ether 2 as a white solid (3.01 g, 85% . Palladium (II) acetate (75 mg, 0.329 mmol, 1.15 equiv) was added to a solution of b-methyl-substituted trimethylsilyl enol ether 2 (163 mg, 0.286 mmol, 1 equiv) in anhydrous dimethyl sulfoxide (3.0 mL) at 23 C. The resulting mixture was heated to 80 C. After stirring at this temperature for 16 h, the reaction mixture was allowed to cool to 23 C. The cooled suspension was diluted with ethyl acetate (20 mL) and the whole was filtered through a pad of Celite. Hexanes (20 mL) were added to the filtrate and the resulting solution was washed sequentially with saturated aqueous sodium bicarbonate solution (20 mL) and saturated aqueous sodium chloride solution (2Â20 mL). The organic phase was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The product was purified by flash-column chromatography (10% ethyl acetate/hexanes), affording the b-methyl- drofuran (11 mL) at À78 C. The resulting colorless solution was stirred at this temperature for 20 min, whereupon a solution of the AB enone 1 (500 mg, 1.04 equiv, 1 equiv) in tetrahydrofuran (3.0 mL) was added dropwise via syringe, forming a bright orangeyellow solution. The reaction solution was allowed to warm slowly to À45 C over 60 min, then chlorotrimethylsilane (199 mL,
1.55 mmol, 1.5 equiv) was added. The (yellow) reaction mixture was stirred at À45 C for 30 min, then was partitioned between aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 20 mL) and dichloromethane (30 mL). The phases were separated and the aqueous phase was extracted with dichloromethane (20 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated, affording an orange-yellow oil. The crude product was purified by flash-column chromatography (6% ethyl acetate/hexanes), providing b-tris(me- in tetrahydrofuran (2.0 mL) at À78 C. The resulting colorless solution was stirred at this temperature for 20 min, whereupon a solution of the AB enone 1 (100 mg, 0.207 mmol, 1 equiv) in tetrahydrofuran (0.4 mL) was added dropwise via syringe, forming a bright orange-yellow solution. The reaction solution was allowed to warm slowly to À45 C over 30 min, then chlorotrimethylsilane (39.7 mL, 0.311 mmol, 1.5 equiv) was added. The resulting (yellow) mixture was allowed to warm to 23 C over 30 min, whereupon methanol (4.0 mL), water (8.0 mL, 2.1 equiv, 500:1 mixture of methanol and water) and N-bromosuccinimide (221 mg, 1.24 mmol, 6.0 equiv) were added in sequence. The reaction mixture was allowed to stir at 23 C for 30 min, then was concentrated. The resulting oily (yellow) suspension was dissolved in dichloromethane (15 mL) and the resulting solution was washed with saturated aqueous sodium bicarbonate solution (15 mL). The phases were separated and the aqueous phase was extracted with dichloromethane (15 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude product was purified by flash-column chromatography (7% acetone/hexanes), providing the b-methyl ester-substituted AB enone 5 as a yellow solid (101 mg, 90%). n-butyllithium in hexanes (2.5 M, 2.91 mL, 7.27 mmol, 1.15 equiv) was added to a solution of 1,3-dithiane (862 mg, 6.95 mmol, 1.1 equiv) in tetrahydrofuran (60 mL) at À78 C. The resulting solution was stirred at this temperature for 30 min, at which point hexamethylphosphoramide (2.44 mL, 13.9 mmol, 2.2 equiv) was added dropwise. After stirring at À78 C for a further 2 min, a solution of the AB enone 1 (3.05 g, 6.32 mmol, 1 equiv) in tetrahydrofuran (15 mL) was added to the reaction solution dropwise via syringe. The brownish-yellow reaction mixture was stirred at À78 C for 40 min whereupon chlorotrimethylsilane (1.20 mL, 9.48 mmol, 1.5 equiv) was added. After stirring at À78 C for 40 min, aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 100 mL) was added to the reaction solution. The resulting mixture was allowed to warm to 23 C, then was extracted with dichloromethane (3Â100 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The product was purified by flash-column chromatography , and the resulting solution was added slowly and carefully to saturated aqueous sodium bicarbonate solution (30 mL). The phases were separated and the aqueous phase was extracted with dichloromethane (30 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. N,N-Diisopropylethylamine (229 mL, 1.31 mmol, 5.0 equiv) and chloromethyl methyl ether (59.8 mL, 0.787 mmol, 3.0 equiv) were added sequentially to a solution of the crude reduction product in benzene (1.5 mL) at 23 C. The reaction flask was sealed and the solution was heated to 50 C. After stirring at 50 C for 24 h, the reaction mixture was allowed to cool to 23 C. The cooled solution was partitioned between dichloromethane (30 mL) and saturated aqueous sodium bicarbonate solution (30 mL). The layers were separated and the aqueous phase was extracted with dichloromethane (30 mL After stirring at À78 C for 30 min, aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 10 mL) was added to the reaction solution. The resulting mixture was allowed to warm to 23 C, then was extracted with ethyl acetate (3Â20 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The product was purified by flash-column added to a solution of b-methoxymethoxymethyl trimethylsilyl enol ether 11 (635 mg, 1.01 mmol, 1 equiv) in anhydrous dimethyl sulfoxide (8.0 mL) at 23 C. The resulting mixture was heated to 50 C. After stirring at this temperature for 14 ½ h, the reaction mixture was allowed to cool to 23 C. The cooled suspension was diluted with ethyl acetate (50 mL) and the whole was filtered through a pad of Celite. Hexanes (50 mL) were added to the filtrate and the resulting solution was washed sequentially with saturated aqueous sodium bicarbonate solution (50 mL) and saturated aqueous sodium chloride solution (50 mL). The aqueous phases were combined and the combined solution was extracted with ethyl acetate/hexanes (1:1, 100 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The product was purified by flash-column chromatography (17% ethyl acetate/hexanes), affording the b-methoxymethoxymethyl AB enone 10 as a pale yellow solid (290 mg, 52%). Concentrated aqueous hydrofluoric acid solution (48 wt %, 2.0 mL) was added to a solution of the MichaeleClaisen cyclization product 14 (249 mg, 0.322 mmol, 1 equiv) in acetonitrile (3.0 mL) in a polypropylene reaction vessel at 23 C. The reaction solution was stirred vigorously at 23 C for 17 h, then was poured into water (100 mL) containing dipotassium hydrogenphosphate trihydrate (20.0 g). The resulting mixture was extracted with ethyl acetate (100 mL, then 2Â50 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated, affording an orange-brown solid. Methanol (3.0 mL) and dioxane (3.0 mL) were added to the crude product, forming an orangebrown solution. Palladium black (13.7 mg, 0.129 mmol, 0.4 equiv) was added in one portion at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 1 h, then was filtered through a plug of Celite. The filtrate was concentrated, affording a brownish yellow solid. The product was purified by preparative HPLC on an Agilent Prep C18 column [10 mm, 250Â21.2 mm, UV detection at 350 nm, solvent A: 0.1% trifluoroacetic acid in water, solvent B: acetonitrile, 2 batches, injection volume: 5.0 mL (4.0 mL 0.1% trifluoroacetic acid in water, 1.0 mL acetonitrile), gradient elution with 5/40% B over 50 min, flow rate: 7.5 mL/min]. Fractions eluting at 24e31 min were collected and concentrated, affording C5a-methylminocycline trifluoroacetate 17 as a yellow solid (188 mg, 100%, two steps). (75 mg, 0.139 mmol, 1 equiv) in tetrahydrofuran (1.5 mL) was added to the reaction solution dropwise via syringe. The resulting mixture was allowed to warm slowly to À10 C over 75 min, then was partitioned between aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 25 mL) and dichloromethane (25 mL). The phases were separated and the aqueous phase was further extracted with dichloromethane (2Â20 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated, affording a yellow solid. Concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added to a solution of the HPLC-purified product 16 from the cyclization step above (25.0 mg, 0.031 mmol, 1 equiv) in acetonitrile (1.2 mL) in a polypropylene reaction vessel at 23 C. The reaction solution was stirred vigorously at 23 C for 17 h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate trihydrate (10.0 g). The resulting mixture was extracted with ethyl acetate (30 mL, then 2Â20 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated, affording an orange solid. Palladium black (4.9 mg, 0.046 mmol, 1.5 equiv) was added in one portion to a solution of the crude product in methanol (1.5 mL) and dioxane (1.5 mL) at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 30 min, then was filtered through a plug of Celite. The filtrate was concentrated, affording a yellow solid. 4.2.17. C5aeC11a-Bridged cyclopropane tetracycline precursor 20. 4 A molecular sieves (2.4 g, small chunks) were added to a solution of the substituted neopentyl alcohol 19 (720 mg, 0.923 mmol, 1 equiv) in dichloromethane (72 mL) and pyridine (7.2 mL) at 23 C. The resulting mixture was stirred at 23 C for 1 h, then was cooled to 0 C. A solution of phosgene in toluene (20 wt %, 537 mL, 1.02 mmol, 1.1 equiv) was added dropwise to the cooled mixture. The resulting solution was stirred at 0 C for 1 h, whereupon aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 20 mL) was added. The resulting mixture was allowed to warm to 23 C, then was filtered to remove the molecular sieves. Dichloromethane (60 mL) and aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 60 mL) were added and the phases were separated. The aqueous phase was further extracted with dichloromethane (2Â60 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated, providing an orange-yellow oil. The product was purified by flash-column chromatography (20% ethyl acetate/hexanes, grading to 30% ethyl acetate/hexanes), affording the C5aeC11a-bridged cyclopropane tetracycline precursor 20 as a white solid (572 mg, 81%). R f ¼0.25 (30% ethyl acetate/hexanes); 1 H NMR (500 MHz, in tetrahydrofuran (0.5 mL) at 23 C. The reaction mixture was stirred at 23 C for 16 h, then was partitioned between dichloromethane and saturated aqueous sodium bicarbonate solution (10 mL each). The phases were separated and the aqueous phase was extracted with dichloromethane (10 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product (21) was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 20 h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate (8.0 g). The resulting mixture was extracted with ethyl acetate (3Â40 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (5.0 mg, 0.047 mmol, 2.8 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane (1.0 mL) at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 1 ¼ h, then was filtered through a plug of Celite. The filtrate was concentrated. The product was purified by preparative HPLC on an in tetrahydrofuran (0.5 mL) at 23 C. The reaction mixture was stirred at 23 C for 21 h, then was heated to 45 C. After stirring at this temperature for 14 h, the reaction mixture was allowed to cool to 23 C. The cooled mixture was partitioned between dichloromethane (15 mL) and saturated aqueous sodium bicarbonate solution (10 mL). The phases were separated and the aqueous phase was extracted with dichloromethane (10 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 13 h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate (8.0 g). The resulting mixture was extracted with ethyl acetate (3Â40 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (5.0 mg, 0.047 mmol, 2.8 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane (1.0 mL) at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 1 ½ h, then was filtered through a plug of Celite. The filtrate was concentrated. in tetrahydrofuran (0.5 mL) at 23 C. The reaction flask was sealed and the reaction mixture was heated to 55 C. After stirring at 55 C for 14 h, the reaction mixture was allowed to cool to 23 C. The cooled mixture was partitioned between dichloromethane and saturated aqueous sodium bicarbonate solution (10 mL each). The phases were separated and the aqueous phase was further extracted with dichloromethane (10 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 16 ½ h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate (8.0 g). The resulting mixture was extracted with ethyl acetate (3Â40 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (5.0 mg, 0.047 mmol, 2.8 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane (25) . Anhydrous magnesium bromide (7.2 mg, 0.039 mmol, 2.0 equiv) was added to a solution of the C5aeC11a-bridged cyclopropane 20 (15.0 mg, 0.020 mmol, 1 equiv) and diethylamine (102 mL, 0.987 mmol, 50 equiv) in tetrahydrofuran (0.5 mL) at 23 C. The reaction flask was sealed and the reaction mixture was heated to 45 C. After stirring at this temperature for 20 h, the reaction mixture was allowed to cool to room temperature. The reaction flask was opened briefly and a second portion of diethylamine (204 mL, 1.97 mmol, 100 equiv) was added. The flask was re-sealed and the reaction mixture was heated to 45 C. After stirring at this temperature for a further 55 h, the reaction mixture was allowed to cool to 23 C. The cooled mixture was partitioned between dichloromethane and saturated aqueous sodium bicarbonate solution (10 mL each). The phases were separated and the aqueous phase was extracted with dichloromethane (10 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 10 ½ h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate (8.0 g). The resulting mixture was extracted with ethyl acetate (3Â40 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (5.0 mg, 0.047 mmol, 2.8 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane ( 
C5a-Methylminocycline (17
CDCl 3 ) d 7.52 (d,
C5a-N-Imidazolylmethylminocycline (26).
Anhydrous magnesium bromide (7.2 mg, 0.039 mmol, 3.0 equiv) was added to a solution of the C5aeC11a-bridged cyclopropane 20 (10.0 mg, 0.013 mmol, 1 equiv) and imidazole (6.2 mg, 0.091 mmol, 7.0 equiv) in tetrahydrofuran (0.5 mL) at 23 C. The reaction flask was sealed and the reaction mixture was heated to 60 C. After stirring at this temperature for 60 h, the reaction mixture was allowed to cool to 23 C. The cooled mixture was partitioned between dichloromethane and saturated aqueous sodium bicarbonate solution (15 mL each). The phases were separated and the aqueous phase was extracted with dichloromethane (15 mL).
The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 18 h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate (8.0 g). The resulting mixture was extracted with ethyl acetate (3Â40 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (5.0 mg, 0.047 mmol, 3.6 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane (1.0 mL) at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 1 ¼ h, then was filtered through a plug of Celite. 10 equiv) in tetrahydrofuran (0.5 mL) at 23 C. The reaction mixture was stirred at 23 C for 16 h, then was heated to 40 C. After stirring at this temperature for 22 h, the reaction mixture was allowed to cool to room temperature. The reaction flask was opened briefly and a second portion of cyclopropylamine (15 mL, 0.223 mmol, 10 equiv) was added. The flask was sealed and the reaction mixture was heated to 40 C. After stirring at this temperature for a further 13 h, the reaction mixture was allowed to cool to 23 C. The cooled mixture was partitioned between dichloromethane (15 mL) and saturated aqueous sodium bicarbonate solution (10 mL). The phases were separated and the aqueous phase was extracted with dichloromethane (10 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 12 h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate (8.0 g). The resulting mixture was extracted with ethyl acetate (3Â40 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (5.0 mg, 0.047 mmol, 2.8 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane (1.0 mL) at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 3 ½ h, then was filtered through a plug of Celite. The filtrate was concentrated. (28) . Anhydrous magnesium bromide (9.1 mg, 0.049 mmol, 2.5 equiv) was added to a solution of the C5aeC11a-bridged cyclopropane 20 (15.0 mg, 0.020 mmol, 1 equiv) in methanol (1.5 mL) at 23 C. The reaction flask was sealed and the reaction mixture was heated to 65 C. After stirring at 65 C for 24 h, the reaction mixture was allowed to cool to 23 C. The cooled mixture was partitioned between aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 10 mL) and dichloromethane (10 mL). The phases were separated and the aqueous phase was extracted with dichloromethane (10 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 15 h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate trihydrate (10.0 g). The resulting mixture was extracted with ethyl acetate (3Â30 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (6.0 mg, 0.057 mmol, 2.8 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane (1.0 mL) at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 2 ½ h, then was filtered through a plug of Celite. 4.2.25. C5a-n-Butoxymethylminocycline (29) . Anhydrous magnesium bromide (7.2 mg, 0.039 mmol, 2.0 equiv) was added to a solution of the C5aeC11a-bridged cyclopropane 20 (15.0 mg, 0.020 mmol, 1 equiv) in n-butanol (1.0 mL) at 23 C. The resulting mixture was heated to 75 C. After stirring at 75 C for 14 h, the reaction mixture was allowed to cool to 23 C. The cooled mixture was partitioned between aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 10 mL) and dichloromethane (10 mL). The phases were separated and the aqueous phase was extracted with dichloromethane (10 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 13 ½ h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate (8.0 g). The resulting mixture was extracted with ethyl acetate (3Â40 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (5.0 mg, 0.047 mmol, 2.4 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane (1.0 mL) at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 3 3 / 4 h, then was filtered through a plug of Celite. The filtrate was concentrated. The product was purified by preparative HPLC on an Agilent Prep C18 column [10 mm, 250Â21.2 mm, UV detection at 350 nm, solvent A: 0.1% trifluoroacetic acid in water, solvent B: acetonitrile, injection volume: 5.0 mL (4.0 mL 0.1% trifluoroacetic acid in water, 1.0 mL acetonitrile), gradient elution with 5/40% B over 50 min, flow rate: 7.5 mL/min]. Fractions eluting at 41e44 min were collected and concentrated, affording C5a-n-butoxymethylminocycline trifluoroacetate 29 as a yellow solid (7.3 mg, 56%, three steps). 1 (30) . Anhydrous magnesium bromide (6.2 mg, 0.034 mmol, 2.0 equiv) was added to a solution of the C5aeC11a-bridged cyclopropane 20 (13.0 mg, 0.017 mmol, 1 equiv) in 2-methoxyethanol (0.5 mL) at 23 C. The resulting mixture was heated to 60 C. After stirring at 60 C for 26 h, the reaction mixture was allowed to cool to 23 C. The cooled mixture was partitioned between aqueous potassium phosphate buffer solution (pH 7.0, 0.2 M, 10 mL) and dichloromethane (10 mL). The phases were separated and the aqueous phase was further extracted with dichloromethane (10 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude ring-opened product was dissolved in acetonitrile (1.2 mL). The resulting solution was transferred to a polypropylene reaction vessel and concentrated aqueous hydrofluoric acid solution (48 wt %, 0.8 mL) was added. The reaction mixture was stirred vigorously at 23 C for 10 ½ h, then was poured into water (30 mL) containing dipotassium hydrogenphosphate (8.0 g). The resulting mixture was extracted with ethyl acetate (3Â40 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Palladium black (5.0 mg, 0.047 mmol, 2.8 equiv) was added in one portion to a solution of the crude product in methanol (1.0 mL) and dioxane (1.0 mL) at 23 C. An atmosphere of hydrogen was introduced by briefly evacuating the flask, then flushing with pure hydrogen (1 atm). The reaction mixture was stirred at 23 C for 1 3 / 4 h, then was filtered through a plug of Celite. The filtrate was concentrated. The product was purified by preparative HPLC on an Agilent Prep C18 column [10 mm, 250Â21.2 mm, UV detection at 350 nm, solvent A: 0.1% trifluoroacetic acid in water, solvent B: acetonitrile, injection volume: 5.0 mL (4.0 mL 0.1% trifluoroacetic acid in water, 1.0 mL acetonitrile), gradient elution with 5/40% B over 50 min, flow rate: 7.5 mL/min]. Fractions eluting at 32e34 min were collected and concentrated, affording C5a-methoxyethoxymethylminocycline trifluoroacetate 30 as a yellow solid (5.8 mg, 52%, three steps). 1 4.2.27. Azido-substituted ring-opened product (31) . Sodium azide (50.0 mg, 0.763 mmol, 3.0 equiv) was added to a solution of the C5aeC11a-bridged cyclopropane 20 (194 mg, 0.255 mmol, 1 equiv) in dimethylformamide (7.5 mL) at 23 C. The resulting solution was stirred at this temperature for 14 h, then was partitioned between saturated aqueous sodium chloride solution and diethyl ether (60 mL each). The phases were separated and the aqueous phase was further extracted with diethyl ether (60 mL). The organic extracts were combined and the combined solution was dried over anhydrous sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The product was purified by flashcolumn chromatography (12% ethyl acetate/hexanes), providing the azido-substituted ring-opened product 31 as a yellow solid (160 mg, 78% 
